Detalhe da pesquisa
1.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA
; 331(1): 49-59, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059899
2.
Circulating tumor DNA in breast cancer: a biomarker for patient selection.
Curr Opin Oncol
; 35(5): 426-435, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551949
3.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
4.
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.
Future Oncol
; 18(22): 2383-2392, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695563
5.
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.
BMC Cancer
; 21(1): 899, 2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362344
6.
Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI.
J Magn Reson Imaging
; 51(5): 1403-1411, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31737963
7.
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
Cancer
; 125(2): 307-316, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30335191
8.
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
BMC Cancer
; 19(1): 304, 2019 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943928
9.
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Adv Anat Pathol
; 24(5): 235-251, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777142
10.
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Adv Anat Pathol
; 24(6): 311-335, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777143
11.
Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.
BMC Med
; 13: 177, 2015 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26234940
12.
Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Curr Opin Oncol
; 27(6): 560-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26335664
13.
Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.
Clin Adv Hematol Oncol
; 13(6): 372-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352893
14.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636208
15.
Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
BMC Genomics
; 15: 1008, 2014 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25412710
16.
International study on inter-reader variability for circulating tumor cells in breast cancer.
Breast Cancer Res
; 16(2): R43, 2014 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24758318
17.
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
Cancer Metastasis Rev
; 32(1-2): 179-88, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129208
18.
Circulating tumor DNA validity and potential uses in metastatic breast cancer.
NPJ Breast Cancer
; 10(1): 21, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472216
19.
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis.
Eur J Cancer
; 194: 113358, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857118
20.
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial.
J Immunother Cancer
; 11(12)2023 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056900